Next Article in Journal
The Bed Nucleus of the Stria Terminalis as a Brain Correlate of Psychological Inflexibility in Fibromyalgia
Next Article in Special Issue
The Impact of the Circadian Genes CLOCK and ARNTL on Myocardial Infarction
Previous Article in Journal
Loss-of-Function Variants in Cytoskeletal Genes Are Associated with Early-Onset Atrial Fibrillation
Previous Article in Special Issue
Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease
Open AccessArticle

Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients

1
Laboratory of Physiology, Department of Translational Medicine, UPO, 28100 Novara, Italy
2
Cardiothoracic Intensive Care Unit, AOU, 28100 Novara, Italy
3
Cardiology Division, AOU, 28100 Novara, Italy
4
Critical Care, OrionPharma, 02101 Espoo, Finland
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(2), 373; https://doi.org/10.3390/jcm9020373
Received: 18 December 2019 / Revised: 22 January 2020 / Accepted: 25 January 2020 / Published: 30 January 2020
The beneficial effects exerted by levosimendan against cardiac failure could be related to the modulation of oxidative balance. We aimed to examine the effects of levosimendan in patients with cardiogenic shock or low cardiac output on cardiac systo-diastolic function and plasma oxidants/antioxidants (glutathione, GSH; thiobarbituric acid reactive substances, TBARS). In four patients undergoing coronary artery bypass grafting or angioplasty, cardiovascular parameters and plasma GSH and TBARS were measured at T0 (before levosimendan infusion), T1 (1 h after the achievement of the therapeutic dosage of levosimendan), T2 (end of levosimendan infusion), T3 (72 h after the end of levosimendan infusion), and T4 (end of cardiogenic shock). We found an improvement in the indices of systolic (ejection fraction, cardiac output, cardiac index) and diastolic (E to early diastolic mitral annular tissue velocity, E/’; early to late diastolic transmitral flow velocity, EA) cardiac function at early T2. A reduction of central venous pressure and pulmonary wedge pressure was also observed. Plasma levels of GSH and TBARS were restored by levosimendan at T1, as well. The results obtained indicate that levosimendan administration can regulate oxidant/antioxidant balance as an early effect in cardiogenic shock/low cardiac output patients. Modulation of oxidative status on a mitochondrial level could thus play a role in exerting the cardio-protection exerted by levosimendan in these patients. View Full-Text
Keywords: antioxidants; calcium sensitizer; heart failure; mitochondria function; peroxidation antioxidants; calcium sensitizer; heart failure; mitochondria function; peroxidation
Show Figures

Figure 1

MDPI and ACS Style

Grossini, E.; Farruggio, S.; Pierelli, D.; Bolzani, V.; Rossi, L.; Pollesello, P.; Monaco, C. Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients. J. Clin. Med. 2020, 9, 373.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop